Diagnosis and Management of the Antiphospholipid Syndrome
NEJM 378:2010-2021, Garcia, D. & Erkan, D., 2018
A Blinding Combination
Lancet 360:1220, Matthews,B.N.,et al, 2002
Stroke in Systemic Lupus Erythematosus
Stroke 21:1533-1539, Kitagawa,Y.,et al, 1990
Anticardiolipin Antibodies and Risk of Ischemic Stroke and Transient Ischemic Attack
Stroke 35:736-741, Janardhan,V.,et al, 2004
Antiphospholipid Antibodies and Stroke in Young Women
Stroke 33:2396-2401, Brey,R.L.,et al, 2002
Anticardiolipin Antibodies & the Risk of Recurrent Thrombo-Occlusive Events & Death
The Antiphospholipid Antibodies & Stroke Study Group, Neurol 48:91-9497., , 1997
IgG Anticardiolipin Antibody Titer>40 GPL & Risk of Subseq Thrombo-Occlusive Events & Death
Stroke 28:1660-1665, Levine,S.R.,et al, 1997
Cerebral Venous Thrombosis and Anticardiolipin Antibodies
Stroke 28:2363-2369, Carhaupoma,J.R.,et al, 1997
Anticardiolipin Antibodies in an Unselected Stroke Population
Lancet 344:452-456, Muir,K.W.,et al, 1994
Anticardiolipin Antibodies are Independ Risk Factor for First Ischemic Stroke
The Antiphospho Antibodies in Stroke, Study (APASS) Group, Neurol 43:2069-20733., , 1993
Acute Cerebrovascular Episodes in Systemic Lupus Erythematosus
Quart J Med 293:739-750, Eustace,S.,et al, 1991
Amaurosis Fugax Associated with Antiphospholipid Antibodies
Ann Neurol 25:228-232, Digre,K.B.,et al, 1989